Related Experiment Videos
[Endothelin-1 in coronary artery disease]
W Myszka1, H Kara-Perz, L Torliński
1Katedra i Zakład Chemii i Biochemii Klinicznej Akademii Medycznej im. Karola Marcinkowskiego w Poznaniu.
Summary
Endothelin-1 (ET-1), a potent vasoconstrictor peptide, plays a significant role in ischemic heart disease. Elevated ET-1 levels are observed in patients with conditions like coronary arteriosclerosis and myocardial infarction.
Area of Science:
- Biochemistry
- Cardiovascular Physiology
- Endocrinology
Context:
- Endothelins (ETs) are peptides synthesized and released by various cells.
- Endothelin ET-1 is the most potent known endothelium-derived vasoconstrictor.
- ET-1 acts via two receptor types, ET-A (vasoconstriction) and ET-B (vasodilation/vasoconstriction).
Purpose:
- To critically review experimental and clinical data on the involvement of endothelin-1 in ischemic heart disease.
- To consolidate evidence supporting ET-1's role in cardiovascular pathologies.
Summary:
- Endothelin ET-1, a 21-amino acid peptide, exhibits potent vasoconstrictive properties.
- Its receptors, ET-A and ET-B, are present in the coronary vascular bed, mediating distinct vascular responses.
- Increased plasma levels of ET-1 correlate with conditions such as coronary arteriosclerosis, acute myocardial infarction, and angina.
Impact:
- Provides a comprehensive overview of ET-1's pathological significance in ischemic heart disease.
- Highlights the potential of targeting the endothelin system for therapeutic interventions in cardiovascular diseases.
- Underscores the importance of ET-1 as a biomarker for ischemic heart conditions.